Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Hair Dyes”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1978

Exploratory skin penetration findings relating to the use of lead acetate hair dyes. Hair as a test tissue for monitoring uptake of systemic lead.

Two experiments were conducted. In the first, 9 adult male subjects applied a marketed hair dye containing 2% lead acetate according to prescribed directions daily for a period of 90 days. Scalp, axillary and pubic hair were monitored for lead content before and at the end of the test period. Scalp hair analyses were used to confirm application of the hair dye; axillary and pubic hair were analyzed as biologic indicators of systemic lead absorption, i.e., metabolic incorporation of lead in hair growing at sites different from the dyed site. The axillary and pubic hair lead levels ranged from less than 6 to 41 ppm at the start and rose to 27 to 466 ppm at the conclusion of the experiment. Using 80 ppm hair lead as a measure of significant systemic absorption, 7 of 9 subjects showed this effect according to uptake by axillary hair and 4 of 9 according to pubic hair uptake. In the second experiment, blood and hair lead levels and blood erythroporphyrin were measured in 11 children from a pica clinic. Blood lead and hair lead levels were significantly correlated, i.e., r = +0.84. A regression formula was constructed relating these two parameters and blood lead values were predicted for the data of experiment 1, using observed hair lead values. The technique has important limitations; nevertheless, within these limitations, 1 of 9 subjects might be expected to have sustained an elevated blood lead level, i.e., in excess of 50 microgram/100 ml. It therefore appears that in the use of lead acetate hair dyes, some lead is absorbed systemically from the scalp.

Adult↗
PubMed1977

Dominant lethal mutagenicity study on hair dyes.

A dominant lethal mutagenicity study was performed in rats with the following chemicals that may be used to dye hair: 2-nitro-p-phenylenediamine, 4-nitro-o-phenylenediamine, m-phenylenediamine, o-phenylenediamine, p-phenylenediamine, p-toluenediamine, 2,4-diaminoanisole, 2,5-diaminoanisole, 2-amino-4-nitrophenol, 2-amino-5-nitrophenol, and 4-amino-2-nitrophenol. The compounds were administered intraperitoneally three times weekly for 8 weeks to groups of 20 sexually mature Charles River CD male rats at a dose of 20 mg/kg. This amount of dye is an enormous exaggeration of the human exposure from brief montly topical application of a hair color product containing 2 g (40 mg/kg) or less total dye. There was no evidence of an increase in postimplantation fetal loss which could indicate a dominant lethal effect. Included are data on the acute toxicity of the dyes by various routes of administration in different vehicles.

Animals↗
PubMed1976

Teratology and percutaneous toxicity studies on hair dyes.

Twelve hair dye formulations were tested for systemic toxicity by topical application twice weekly for 13 wk to groups of 12 New Zealand white rabbits and for teratologic effects following applications to groups of 20 pregnant Charles River CD rats on days 1, 4, 7, 10, 13, 16, and 19 of gestation. The three semipermanent formulations were applied as is, and the nine oxidation dyes were mixed 1:1 with 6% hydrogen peroxide just prior to application, as in normal use. The formulations induced a broad spectrum of dyes and dye intermediates used or considered useful in oxidative and semipermanent hair color products. In the teratology study no biologically significant soft tissue or skeletal changes were noted. Similarly, the mean numbers of corpora lutea, implantation sites, live fetuses, and resorptions per pregnancy, as well as numbers of litters with resporptions, were not significantly affected by the dye treatment. In the percutaneous toxicity study there was no evidence of compound-induced systemic effects. Microscopic examination of 25 tissues from each animal gave no indication of histomorphologic evidence of toxicity. No dye discoloration of urine was seen at any time during the test or at necropsy. Some of the dye groups showed epidermal hyperplasia, which was probably a reflection of slight irritation due to the frequency of application of the oxidation formulations.

Abnormalities, Drug-Induced↗
PubMed1979

A case-control study of hair dye use and breast cancer.

A case-control study of the relationship between hair dye use and breast cancer included 129 breast cancer patients and 193 control women drawn from the records of a multiphasic screening clinic. Information was obtained by telephone interview on a number of risk factors for breast cancer and on variables pertaining to hair dye use: chronologic time, duration, frequency, type, and color. From this, quantitative measures of cumulative hair dye use at various intervals prior to breast cancer (or an equivalent for controls) were obtained. A multivariate risk factor score was used to control for confounding variables. The adjusted relative risks for breast cancer versus hair dye use were greater than unity but were not generally significant. However, integral measures of hair dye use (No. of yr times frequency per yr) were significantly related to breast cancer when confounding variables were controlled. The association between hair dye use and breast cancer was greatest among women over 50 years of age and among those at lower natural risk for breast cancer. An analysis of temporal patterns showed that breast cancer was related mainly to hair dye use 10 or more years before cancer diagnosis. Because of the retrospective nature of the hair dye data and the small sample size, these results require further validation.

Adult↗
PubMedDate not supplied

Hair dye toxicity--a review.

This article reviews local and systemic effects which relate to hair dye formulation and hair dye ingredient tests and experiences in man and animals. Mutagenic and carcinogenic aspects are discussed. In a very limited way, safety and hazards of using hair dyes are interpreted for consumers.

Animals↗
PubMed1979

Cataractogenous effect of hair dyes: a clinical and experimental study.

Observations based on a clinical and experimental study of the effect of hair dye (paraphenylenediamine) on the lens are reported. Two hundred individuals of either sex using hair dye were examined in detail and lenticular changes were found in 89% while only 23% in controls. The lenticular changes were related to duration, amount, and individual sensitivity to dye. Various types of lenticular opacities encountered are mentioned. In addition some individuals (7%) were found to develop early presbyopia. Experimental study which was conducted in rats and rabbits confirmed the cataractogenic effect of hair dye beyond doubt. It is concluded that hair dye is potentially toxic to the human lens.

Adult↗
PubMed1977

Use of hair dyes by patients with breast cancer: a case-control study.

The recent finding that many permanent and semipermanent hair dyes are strongly mutagenic in a laboratory test, together with the fact that single female hair-dressers had higher than expected death rates from breast-cancer in 1959-63, prompted a study into the use of hair dyes by patients with breast cancer and by matched controls. There was no difference between the patients and their controls in their use of hair dyes. There were also no significant differences between the two groups when the analysis was confinedto women who had used dyes over four years and over nine years before diagnosis. The only significant findings were a higher proportion of past or present smokers among women aged over 50 who used hair dyes and an association between hair dyes use and age at first pregnancy. Further epidemiological studies are clearly needed in view of the mutagenicity found in the Ames test, and the fact th & several human carcinogens are also mutagenic according to this test.

Age Factors↗
PubMedDate not supplied

Hair dyes and aplastic anemia.

Reports linking the use of hair dyes with bone marrow suppression and aplastic anemia have appeared sporadically over the past 45 years. For the most part these clinical cases are difficult to evaluate but appear to rely heavily for support on a single report in 1935. The infrequency of these reports and the wide-spread use of hair color products argue strongly against a primary toxic action on bone marrow in humans. The results of studies in three species of animals support this conclusion, giving no indication that chronic exposure to hair dyes causes adverse effects on hematopoiesis. Although it cannot be dismissed as a possibility, invoking idiosyncrasy seems on equally shaky grounds since any rational basis for continued association of a substance with individual sensitivity should find increasing numbers of cases with increasing population exposure. Clearly this has not been the case.

Anemia, Aplastic↗
PubMed1977

Effects of repeated applications of two semi-permanent hair dyes to the skin of A and DBAf mice.

Two proprietary semi-permanent hair dyes were tested for carcinogenicity in A and DBAf mice by repeated topical applications in aqueous acetone. Mice of both strains developed lymphoid tumours but experimental differences were marked only in DBAf mice. A number of tumours of the ovary and uterus, and some skin papillomas near the penis, occured in dye-treated but not in control DBAf mice. As many hair-dye constituents are known mutagens, adequate carcinogenicity testing of these substances, and epidemiological study of exposed human populations, are needed for evaluating possible health hazard from hair dyeing.

Animals↗
PubMed1975

Hair dyes are mutagenic: identification of a variety of mutagenic ingredients.

We have previously described a sensitive bacterial test for dectecting carcinogens as mutagens. We have previously described a sensitive bacterial test for detecting carcinogens as mutagens. We show here that 89% (150/169) of commercial oxidative-type (hydrogen peroxide) hair dye formulations are mutagenic in this test. Of the 18 components of these hair dyes, nine show various degrees of mutagenicity:2,4-diaminoanisole, 4-nitro-o-phenylenediamine, 2-nitro-p-phenylenediamine, 2,5-diaminoanisole, 2-amino-5-nitrophenol, m-phenylenediamine, o-phenylenediamine, 2-amino-4-nitrophenol, and 2,5-diaminotoluene. Three hair dye components (p-phenylenediamine, 2,5-diaminotuluene, and 2,5-diaminoanisole) become strongly mutagenic after oxidation by H2O2: the mutagenic product of p-phenylenediamine is identified as the known trimer, Bandrowski's base. 2,4-Diaminotoluene, a hair dye component until recently, is also shown to be mutagenic: this compound has been shown to be a carcinogen in rats and is used in large amounts in the polyurethane foam industry. About 20,000,000 people (mostly women) dye their hair in the U.S. and the hazard could be considerable if these chemicals are actually mutagenic and carcinogenic in humans.

Amines↗
PubMed1977

Mutagenicity of four hair dyes in Drosophila melanogaster.

The hair dye constituents p-phenylenediamine, 2,4-diaminoanisole sulfate, 2,4-diaminotoluene and 4-nitro-0-phenylenediamine were tested for mutagenicity in Drosophila melanogaster. The compounds were given orally to adult males. The induction of sex-linked recessive lethal mutation was used as a measure of mutagenicity. All four of the dyes tested were mutagenic with a peak mutagenic activity in metabolically active germ cells (spermatids and spermatocytes).

Animals↗
PubMedDate not supplied

The mutagenic assay of some hair dye components, using the thymidine kinase locus of L5178Y mouse lymphoma cells.

Five hair dye components were tested for their mutagenicity at the TK +/- locus of L5178Y cells. Three of the components, m-phenylenediamine, 2 nitro-p-phenylenediamine, and 4-nitro-o-phenylenediamine, gave a positive response that was dose related; 2,4-diaminoanisole gave a questionable response; and 2,5-diaminoanisole gave a negative response. The assay was carried out in vitro without metabolic activation during a 24-hr chemical exposure period. It is concluded that further in vivo tests are necessary to establish the safety of the hair dyes.

Animals↗
PubMed1975

Percutaneous penetration following use of hair dyes.

We assess the percutaneous penetration potential of two commercially distributed semipermanent hair dyes. Utilizing several solvent systems in conjunction with thin-layer chromatography (TLC), we found that the commercial formulations contained at least nine component chemicals. Eight adult volunteers had their hair dyed with these preparations and 24-hour urine specimens were collected daily for five days. The urine was lyophilized and extracted with diethyl ether under acid and alkaline conditions. The TLC of urine from four of the eight subjects, taken from one to four days after dyeing the hair, disclosed a purple spot. This spot, though not identified, was the same with both dye preparations. It is likely that these hair dyes not uncommonly penetrate the skin.

Adult↗
PubMed1979

Detection of mutagens in the urine of rats following topical application of hair dyes.

Mutagens were detected in the urine of rats following topical application of two commercial oxidative-type hair dye preparations. The test system used was induction of back mutation with the bacterial tester strain TA1538, a histidine-dependent mutant of Salmonella typhimurium. Various quantities of dye were applied to the shortened hair on the backs of the test animals. The dye was allowed to remain on the hair for 20 min after application and was then removed by shampooing and thorough rinsing. Maximal levels of mutagenic activity occurred with urine collected during first 24 h following dye application, and a dose--response was observed when increasing volumes of mutagenic urine were tested. Mutagens were detected in rat urine after intraperitoneal injection, and also after topical application of 4-nitro-o-phenylenediamine, one of the constituents of the hair-dye preparations.

Administration, Topical↗
PubMed1976

Dermal carcinogenicity study by mouse-skin painting with 2,4-toluendediamine alone or in representative hair dye formulations.

The chronic toxicity of 2,4-toluenediamine (2,4-TDA) alone or in conbination with a hair dye complex (2,5-toluenediamine, p-phenylenediamine, and resorcinol) was studied in Swiss-Webster mice of both sexes by a skin-painting technique. The predominant neoplasms seen in these mice were primary pulmonary adenomas and adenocarcinomas. Skin neoplasms were seen in most groups of mice, including untreated control mice. Statistical analysis of the incidences of skin neoplasms among the various groups of mice did not show any significant differences. The 2,4-TDA alone or mixed with the hair dye complex did not produce any abnormal proliferation and maturation of the squamous epithelium of the skin. The 2,4-TDA under our experimental conditions was found to be nontoxic and noncarcinogenic to the skin of mice.

9,10-Dimethyl-1,2-benzanthracene↗
PubMed1979

Dominant lethal assay of some hair-dye components in random-bred male rats.

Male rats were exposed to maximally tolerated doses of 5 hair-dye components in a dominant lethal test. Each component was tested at 3 dosage levels with 15 random-bred male rats per level. The highest dose, selected on the basis of subacute toxicity testing, generally reduced weight gains without being lethal. Freshly prepared solutions were injected i.p. at 1 ml/kg 3 times a week for 10 weeks. Rats injected with dimethylsulfoxide and triethylenemelamine served as solvent and positive controls, respectively. A majority of rats survived the treatment at the levels tested and were mated to two virgin females each per week for 2 weeks. The females were sacrificed at midterm of pregnancy and examined for live and dead implants. Dominant lethality was evaluated on the basis of 4 criteria: dead implants per pregnant female, dead implants per total implants, proportion of females with one or more dead implants, and proportion of females with two or more dead implants. 2-Nitro-p-phenylenediamine, 2,4-diaminoanisole sulfate and 2,5-diaminoanisole sulfate produced negative responses, whereas m-phenylenediamine and 4-nitro-o-phenylenediamine induced weak dominant lethality in the first trial. On retesting these weakly positive components, both m-phenylenediamine and 4-nitro-o-phenylenediamine produced negative responses.

Animals↗
PubMed1979

Case-control study of hair dye use by patients with breast cancer and endometrial cancer.

A case-control study was undertaken of use of permanent and semipermanent hair dyes by women with cancers of several sites, including breast and endometrium. In London, Ontario, 50 cases of of breast cancer and in Toronto 35 cases of breast cancer and 36 cases of endometrial cancer were identified in cancer treatment centers. In London, controls were selected from hospitalized women with diseases other than cancer; in Toronto, controls were selected from women living in the same neighborhood as the patients with cancer. The results did not suggest an increased risk of either breast or endometrial cancer in users of permanent or permanent and semipermanent dyes combined. Although the numbers of cases and controls were small, the consistency of the results for both sites, in both study centers, and the absence of any clear positive relationship between various measures of intensity of use and risk of cancer provided evidence that a large increase in risk was not missed.

Adult↗